Xcopri is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Sk Life Science, Inc.. The primary component is Cenobamate.
| Product ID | 71699-200_0834bd13-0cac-4670-9ed4-d0d6fed1d4ad | 
| NDC | 71699-200 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Xcopri | 
| Generic Name | Cenobamate | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2020-03-12 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA212839 | 
| Labeler Name | SK Life Science, Inc. | 
| Substance Name | CENOBAMATE | 
| Active Ingredient Strength | 200 mg/1 | 
| DEA Schedule | CV | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2020-03-12 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA212839 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-03-12 | 
| Ingredient | Strength | 
|---|---|
| CENOBAMATE | 200 mg/1 | 
| SPL SET ID: | 565c2126-57ae-4e29-b443-723bbe7e2072 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 71699-050 | Xcopri | cenobamate | 
| 71699-100 | Xcopri | cenobamate | 
| 71699-102 | Xcopri | cenobamate | 
| 71699-103 | Xcopri | cenobamate | 
| 71699-104 | Xcopri | cenobamate | 
| 71699-150 | Xcopri | cenobamate | 
| 71699-200 | Xcopri | Xcopri | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  XCOPRI  88485671  not registered Live/Pending | SK BIOPHARMACEUTICALS CO., LTD. 2019-06-24 | 
|  XCOPRI  88484180  not registered Live/Pending | SK BIOPHARMACEUTICALS CO., LTD. 2019-06-21 | 
|  XCOPRI  87349251  5426093 Live/Registered | SK Biopharmaceuticals Co., Ltd. 2017-02-24 |